At Reach Fund Capital, we invest in companies driving the next generation of innovation across pharmaceuticals and chemistry.
From early-stage breakthroughs to growth-stage expansion, we provide more than capital. We bring strategic guidance, operational expertise, and direct access to a global industry network.
Our objective is clear: to help science-driven businesses scale efficiently and translate innovation into commercial success.
We believe that building successful companies requires more than financial investment. Our approach combines capital with deep sector expertise and hands-on involvement.
Industry Expertise
Extensive experience across pharmaceutical and chemical industries, from development through to commercialization.
Strategic Network
Access to a broad network of industry leaders, partners, and decision-makers across global markets.
Operational Involvement
Active support in scaling operations, optimizing processes, and navigating complex regulatory environments.
Long-Term Partnership
We invest with a long-term perspective and support companies across multiple stages of growth.
Pharmaceuticals & Biotechnology
Specialty Chemicals
Advanced Materials
Process Innovation & Industrial Chemistry
Early-stage (Seed / Series A)
Growth-stage (Series B and beyond)
We partner with companies that demonstrate:
Scalable and robust business models
A well-defined path toward commercialization and value creation
We operate with focus, speed, and precision throughout the investment lifecycle.
Initial Assessment
Rapid evaluation of strategic fit, technology, and market potential.
In-Depth Due Diligence
Comprehensive scientific, technical, and commercial analysis.
Investment & Partnership Structuring
Tailored transaction structures aligned with long-term value creation.
